Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8K7P

Staphylococcus aureus lipase -PSA complex

8K7P の概要
エントリーDOI10.2210/pdb8k7p/pdb
分子名称Lipase 2, MAGNESIUM ION, ZINC ION, ... (15 entities in total)
機能のキーワードlipase inhibitor complex, hydrolase
由来する生物種Staphylococcus aureus
タンパク質・核酸の鎖数2
化学式量合計94891.61
構造登録者
Kitadokoro, J.,Kamitani, S.,Kitadokoro, K. (登録日: 2023-07-27, 公開日: 2024-06-05, 最終更新日: 2024-06-19)
主引用文献Kitadokoro, J.,Kamitani, S.,Okuno, Y.,Hikima, T.,Yamamoto, M.,Hirokawa, T.,Kitadokoro, K.
Crystal structure of Staphylococcus aureus lipase complex with unsaturated petroselinic acid.
Febs Open Bio, 14:942-954, 2024
Cited by
PubMed Abstract: Staphylococcus aureus produces large amounts of toxins and virulence factors. In patients with underlying diseases or compromised immune systems, this bacterium can lead to severe infections and potentially death. In this study, the crystal structure of the complex of S. aureus lipase (SAL), which is involved in the growth of this bacterium, with petroselinic acid (PSA), an inhibitor of unsaturated fatty acids, was determined by X-ray crystallography. Recently, PSA was shown to inhibit S. aureus biofilm formation and the enzymatic activity of SAL. To further characterize the inhibitory mechanism, we determined the half-inhibitory concentration of SAL by PSA and the crystal structure of the complex. The IC of the inhibitory effect of PSA on SAL was 3.4 μm. SAL and PSA inhibitors were co-crystallized, and diffraction data sets were collected to 2.19 Å resolution at SPring-8 to determine the crystal structure and elucidate the detailed structural interactions. The results show that the fatty acid moiety of PSA is tightly bound to a hydrophobic pocket extending in two directions around the catalytic residue Ser116. Ser116 was also covalently bonded to the carbon of the unsaturated fatty acid moiety, and an oxyanion hole in SAL stabilized the electrons of the double bond. The difference in inhibitory activity between PSA and ester compounds revealed a structure-activity relationship between SAL and PSA. Additional research is required to further characterize the clinical potential of PSA.
PubMed: 38757397
DOI: 10.1002/2211-5463.13808
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.19 Å)
構造検証レポート
Validation report summary of 8k7p
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon